These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 8389668)

  • 21. Application of whole-body positron emission tomography in the imaging of esophageal cancer: report of a case.
    Yasuda S; Raja S; Hubner KF
    Surg Today; 1995; 25(3):261-4. PubMed ID: 7640457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
    Newman JS; Francis IR; Kaminski MS; Wahl RL
    Radiology; 1994 Jan; 190(1):111-6. PubMed ID: 8259386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin.
    Kaya AO; Coskun U; Unlu M; Akdemir UO; Ozdemir NY; Zengin N; Benekli M; Yildiz R; Yaman E; Ozturk B; Gumus M; Uner A; Yamac D; Ucgul E; Buyukberber S
    Asian Pac J Cancer Prev; 2008; 9(4):683-6. PubMed ID: 19256759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
    Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
    Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings.
    Konishi J; Yamazaki K; Tsukamoto E; Tamaki N; Onodera Y; Otake T; Morikawa T; Kinoshita I; Dosaka-Akita H; Nishimura M
    Respiration; 2003; 70(5):500-6. PubMed ID: 14665776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer.
    Kahn D; Menda Y; Kernstine K; Bushnell D; McLaughlin K; Miller S; Berbaum K
    Chest; 2004 Feb; 125(2):494-501. PubMed ID: 14769730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis.
    Dewan NA; Reeb SD; Gupta NC; Gobar LS; Scott WJ
    Chest; 1995 Aug; 108(2):441-6. PubMed ID: 7634881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer.
    Brink I; Schumacher T; Mix M; Ruhland S; Stoelben E; Digel W; Henke M; Ghanem N; Moser E; Nitzsche EU
    Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1614-20. PubMed ID: 15258700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
    Lassen U; Daugaard G; Eigtved A; Damgaard K; Friberg L
    Eur J Cancer; 1999 Jul; 35(7):1076-82. PubMed ID: 10533451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of extrathoracic metastases by positron emission tomography in lung cancer.
    Weder W; Schmid RA; Bruchhaus H; Hillinger S; von Schulthess GK; Steinert HC
    Ann Thorac Surg; 1998 Sep; 66(3):886-92; discussion 892-3. PubMed ID: 9768946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
    Moog F; Bangerter M; Diederichs CG; Guhlmann A; Kotzerke J; Merkle E; Kolokythas O; Herrmann F; Reske SN
    Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancer.
    Shen YY; Shiau YC; Wang JJ; Ho ST; Kao CH
    Anticancer Res; 2002; 22(2B):1257-64. PubMed ID: 12168935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of whole-body FDG PET in management of lung cancer.
    Higashi K; Matsunari I; Ueda Y; Ikeda R; Guo J; Oguchi M; Tonami H; Yamamoto I
    Ann Nucl Med; 2003 Feb; 17(1):1-14. PubMed ID: 12691125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [18F]FLT PET for diagnosis and staging of thoracic tumours.
    Dittmann H; Dohmen BM; Paulsen F; Eichhorn K; Eschmann SM; Horger M; Wehrmann M; Machulla HJ; Bares R
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1407-12. PubMed ID: 12898201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.
    Linke R; Schroeder M; Helmberger T; Voltz R
    Neurology; 2004 Jul; 63(2):282-6. PubMed ID: 15277621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
    J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
    Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I
    J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An assessment of
    So A; Pointon O; Hodgson R; Burgess J
    Clin Endocrinol (Oxf); 2018 May; 88(5):683-691. PubMed ID: 29446832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Brain metastases of lung cancer: diagnostic accuracy of positron emission tomography with fluorodeoxyglucose (FDG-PET)].
    Palm I; Hellwig D; Leutz M; Rentz K; Hellwig A; Kirsch CM; Ukena D; Sybrecht GW
    Med Klin (Munich); 1999 Apr; 94(4):224-7. PubMed ID: 10373759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.